Skip to Content
Print Save

435 (Mesalamine Delayed-Release 800 mg)

Pill with imprint 435 is Brown, Capsule-shape and has been identified as Mesalamine Delayed-Release 800 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..

Mesalamine is used in the treatment of crohn's disease, maintenance; inflammatory bowel disease; ulcerative colitis, maintenance; ulcerative colitis, active; ulcerative proctitis and belongs to the drug class 5-aminosalicylates. excluding Asacol and Asacol HD: There is no proven risk in humans during pregnancy. Asacol and Asacol HD: Risk cannot be ruled out during pregnancy. Mesalamine 800 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 435

Mesalamine delayed-release 800 mg 435
Mesalamine delayed-release 800 mg 435

Save up to 80% off prescription medications

Click here for your free Discount Card

Mesalamine Delayed-Release

Imprint
435
Strength
800 mg
Color
Brown
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
5-aminosalicylates
Pregnancy Category
B - No proven risk in humans - excluding Asacol and Asacol HD, C - Risk cannot be ruled out - Asacol and Asacol HD
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals (USA) Inc.
Manufacturer
Cadila Healthcare Limited
National Drug Code (NDC)
70771-1110
Inactive Ingredients
acetyltributyl citrate, silicon dioxide, ferric oxide red, magnesium stearate, methacrylic acid, microcrystalline cellulose, povidone, sodium starch glycolate type A potato, magnesium silicate, titanium dioxide, ferrosoferric oxide, isopropyl alcohol, butyl alcohol, propylene glycol, ammonia, shellac

Note: Inactive ingredients may vary.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Related Images for "435"

Metformin Hydrochloride
Acamprosate Calcium Delayed-Release
Zaldyon

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer